H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH manufacturers
- (Arg)9
-
-
2026-05-11
- CAS:143413-47-2
- Purity:
- Supply Ability: 10g
|
| | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH Basic information |
| Product Name: | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | | Synonyms: | H-RRRRRRRRR-NH2;Nonaarginine;H(-Arg)9-OH, Nonaarginine;(Arg)9 peptide;Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg;Poly Arginine 9|(Arg)9 peptide|RRRRRRRRR;Poly Arginine 9|(Arg)9 NJ-Peptide;L-Arginine,L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl- | | CAS: | 143413-47-2 | | MF: | C54H110N36O10 | | MW: | 1423.69 | | EINECS: | | | Product Categories: | peptide | | Mol File: | 143413-47-2.mol |  |
| | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | Sequence | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH |
| | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH Usage And Synthesis |
| Uses | (Arg)9 (Nona-L-arginine) is a cell-penetrating peptide (CPP) made up of 9 arginine residues, which is an inhibitor of serine endoprotease Furin. (Arg)9 has neuroprotective property, exhibits neuroprotective activity with an IC50 of 0.78 μM in the glutamic acid model[1][2]. | | Biological Activity | (Arg)9 (Nona-L-arginine; Peptide R9) is a cell-permeable polypeptide with IC50 value of 0.78 μM for neuroprotection in a glutamate model experimental model. | | in vitro | Poly-arginine (eg (Arg)9) and arginine-rich peptides (eg TAT, penetratin), which belong to a class of peptides with cell-penetrating properties are neuroprotective. It provides significant neuroprotection in a dose–response manner following glutamic acid exposure (IC 50 =0.78 μM). Following kainic acid exposure, (Arg)9 is neuroprotective, but less effective than in the glutamic acid model (IC 50 =0.81 μM). (Arg)9 also shows neuroprotection following in vitro ischemia (IC 50 =6 μM). | | in vivo | (Arg)9) (D-isoform) is neuroprotective in rat stroke models. (Arg)9) is highly neuroprotective, with efficacy increasing with increasing arginine content, has the capacity to reduce glutamic acid-induced neuronal calcium influx and requires heparan sulfate preotoglycan-mediated endocytosis to induce a neuroprotective effect. (Arg)9) (D-isoform) administered intravenously at a dose of 1000 nmol/kg 30 min after reduces permanent middle cerebral artery occlusion (MCAO) infarct volume . | | target | IC50: 0.78 μM (neuroprotection) | | References | [1] Cameron A, et al. Polyarginines are potent furin inhibitors. J Biol Chem. 2000 Nov 24;275(47):36741-9. DOI:10.1074/jbc.M003848200
[2] Meloni BP, et, al. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Cell Mol Neurobiol. 2014 Mar;34(2):173-81. DOI:10.1007/s10571-013-9999-3
[3] Meloni BP, et, al. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. J Cereb Blood Flow Metab. 2015 Jun;35(6):993-1004. DOI:10.1038/jcbfm.2015.11 |
| | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH Preparation Products And Raw materials |
|